Method to enhance thrombomodulin APC generation using cationic proteins

Arne Slungaard

Research output: Contribution to journalArticlepeer-review


A method of inhibiting blood coagulation in a patient is provided. This method involves administering to the patient an effective anticoagulant amount of a cationic protein; wherein the cationic protein has an isoelectric point of at least about 7.4, and is capable of enhancing the production of activated protein C by a thrombomodulin-thrombin complex by a factor of at least about two. A particularly preferred cationic protein is purified Platelet Factor 4.

Original languageEnglish (US)
Pages (from-to)766
Number of pages1
JournalBiotechnology Advances
Issue number3-4
StatePublished - 1997


Dive into the research topics of 'Method to enhance thrombomodulin APC generation using cationic proteins'. Together they form a unique fingerprint.

Cite this